Skip to content
TrialScanner

NCT03398837

Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis

Phase 3TerminatedCRBPLead

Registry record

Lead sponsor
Corbus Pharmaceuticals Inc.
Conditions
Diffuse Cutaneous Systemic Sclerosis
Primary completion
May 27, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03398837 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03398837: Trial to Evaluate Efficacy... | TrialScanner